Android app on Google Play

Canaccord Genuity Downgrades Teva Pharma (TEVA) to Hold

February 8, 2013 7:17 AM EST Send to a Friend
Get Alerts TEVA Hot Sheet
Price: $50.85 --0%

Rating Summary:
    13 Buy, 16 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade TEVA Now!
Join SI Premium – FREE
Canaccord Genuity downgraded Teva Pharma (NYSE: TEVA) from Buy to Hold with a price target of $45.00 (from $50.00) following Q4 results.

For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.

Shares of Teva Pharma closed at $37.96 yesterday.




You May Also Be Interested In


Related Categories

Analyst EPS View, Analyst PT Change, Downgrades

Related Entities

Canaccord Genuity

Add Your Comment